CENTRAL DISTRICT - 1Globe Biomedical today announced it will team up with an Indian Biotech company and make a significant investment in research and technology.
CENTRAL DISTRICT - 1Globe Biomedical today presented their comprehensive global study on Molecular Colorectal Cancer with research spanning 5 years from 2015 to 2020.
1Globe Biomedical today announced that its scientists are testing materials used in medical implants to analyze the immune response to reduce implant rejection.
CENTRAL DISTRICT - 1Globe Biomedical of Hong Kong announced today that they will host their Third Quarter financial results conference on in the last week of October.
CENTRAL DISTRICT - 1Globe Biomedical of Hong Kong today announced details of their upcoming Health Conference which will be held on Hong Kong on Thursday 29th October 2020.
CENTRAL DISTRICT - 1Globe Biomedical today announced it is teaming up with a Korean biomedical firm to accelerate the production of T-cell based cancer treatments and tumors.
CENTRAL DISTRICT - 1Globe Biomedical today announced the appointment of Dr. Thomas Parker PhD as the company’s new Chief Medical Officer effective immediately.
Satisfied Users & 
Approved Press Releases
